The short answer
Coenzyme Q10 may interfere with warfarin control, but human findings are inconsistent. Labeling lists a possible reduction in warfarin effect, while a small controlled trial found no change in INR or required warfarin dose. A separate observational study reported more bleeding among users. None establishes that CoQ10 reliably reduces warfarin absorption.
What this answer covers
Oral coenzyme Q10 supplements with oral warfarin. The controlled trial evaluated 100 mg daily; it does not establish equivalence among ubiquinone, ubiquinol or different formulations.
- Supplement or preparation
- Coenzyme Q10
- Medication ingredient
- warfarin
What does the evidence show?
In a randomized crossover trial, 24 stable warfarin outpatients received CoQ10, ginkgo and placebo during separate periods; 21 completed the study. Four weeks of CoQ10 at 100 mg/day did not significantly change the average warfarin dose needed to maintain INR. Conversely, a 171-patient observational study associated CoQ10 use with more self-reported bleeding. Product use was not randomized, and residual confounding is possible. Together with the label's decreased-effect warning, these findings support caution while leaving the direction and magnitude uncertain.
Which forms and conditions matter?
CoQ10 is sold in different chemical and delivery forms. The trial’s dose and preparation cannot establish safety for every softgel, higher dose or mixed supplement. The available clinical studies do not demonstrate that reduced absorption explains the reported changes in warfarin response.
What should I discuss with my care team?
Discuss starting or stopping CoQ10 with the anticoagulation service and keep a record of the formulation and daily amount. The clinician can decide how to monitor warfarin response around the change. There is no verified timing interval in these sources that eliminates a CoQ10 interaction, and an INR change should not be managed by self-adjusting either product.
How certain is the answer?
The controlled trial was small and brief, while the observational study cannot establish causation. Conflicting signals should be visible in the explanation rather than reduced to a single confident warning or a declaration of safety. A stable result for one person or one product does not establish that all future changes will be harmless.
Evidence and practical considerations
Absorption & effectiveness
Coenzyme Q10 may interfere with warfarin control, but human findings are inconsistent. Labeling lists a possible reduction in warfarin effect, while a small controlled trial found no change in INR or required warfarin dose. A separate observational study reported more bleeding among users. None establishes that CoQ10 reliably reduces warfarin absorption.
- Exact scope
- Oral coenzyme Q10 supplements with oral warfarin. The controlled trial evaluated 100 mg daily; it does not establish equivalence among ubiquinone, ubiquinol or different formulations. with Oral warfarin, including warfarin sodium tablets with the warfarin active moiety.
- Medication form and route
- oral warfarin
- Timing or duration
- Study-specific durations are described in each source exposure; no universally safe exposure duration has been established.
What remains uncertain
- The controlled trial was small and brief, while the observational study cannot establish causation. Conflicting signals should be visible in the explanation rather than reduced to a single confident warning or a declaration of safety. A stable result for one person or one product does not establish that all future changes will be harmless.
Factors that may matter: Exact supplement preparation and other ingredients; Starting, stopping or changing supplement intake; Baseline anticoagulation control and clinician-supervised monitoring.
Read the supporting source summaries
Source 1: current U.S. regulatory prescribing information
dailymed.nlm.nih.gov · Source check Sep 10, 2026
Population: Patients prescribed oral warfarin sodium tablets.
The label advises closer INR monitoring when botanicals are started or stopped, identifies variable botanical composition and lists selected potential interactions. Vitamin K intake should remain consistent.
How this applies: Oral warfarin sodium has warfarin as its active moiety. Label-level botanical and vitamin K monitoring advice applies; it is not proof of this exact supplement effect. Oral coenzyme Q10 supplements with oral warfarin. The controlled trial evaluated 100 mg daily; it does not establish equivalence among ubiquinone, ubiquinol or different formulations.
Regulatory precautions do not quantify the incidence for every exact preparation or prove an interaction for an unlisted ingredient. Warfarin sodium is bridged to the warfarin active moiety only for the oral product.
Source 2: peer-reviewed original research
pubmed.ncbi.nlm.nih.gov · Source check Sep 10, 2026
Population: 24 outpatients on stable long-term warfarin; three withdrew.
INR remained stable and mean weekly warfarin dose did not differ significantly across periods.
How this applies: This crossover tested both Ginkgo biloba and coenzyme Q10 separately with warfarin. Use only the arm corresponding to the package supplement; no evidence for another botanical. Exact package scope: Oral coenzyme Q10 supplements with oral warfarin. The controlled trial evaluated 100 mg daily; it does not establish equivalence among ubiquinone, ubiquinol or different formulations.
Small short crossover with adjusted warfarin doses; cannot exclude rare events, different products or larger doses.
Source 3: peer-reviewed original research
pubmed.ncbi.nlm.nih.gov · Source check Sep 10, 2026
Population: 171 adults expected to receive warfarin for at least four months.
CoQ10 and ginger use were associated with more self-reported bleeding after adjustment; associations did not establish a product-specific causal mechanism.
How this applies: Use only the corresponding coenzyme Q10 or ginger association. Observational self-report cannot isolate causation or establish exact ginger root-powder equivalence. Exact package scope: Oral coenzyme Q10 supplements with oral warfarin. The controlled trial evaluated 100 mg daily; it does not establish equivalence among ubiquinone, ubiquinol or different formulations.
Observational, self-reported exposure and outcomes, possible residual confounding and multiple supplements; cannot establish reduced warfarin absorption or a risk estimate for an exact branded preparation.
Research assessment: · Open full citations ↗
Review and change history
- Publication status
- Published research summary
- Clinical review
- Not yet recorded
| Date | Update |
|---|---|
| Article prepared | |
| Original evidence and contradictory findings assessed for this exact pair. Article drafted and existing statements adjudicated. Clinical sign-off has not been recorded. | |
| Consumer explanations clarified without changing the evidence assessment. | |
| Research summary published |
Article revision: 7d9f8b0173db5ba6
This guide brings together the evidence records used by our interaction checker. Each finding retains its own preparation limits, research date, and source summaries.
Full citations require verification. Reading this answer and the source summaries does not.
Taking other supplements or medications?
Use the checker to explore your other combinations. Ask a pharmacist to review the exact products, amounts and medical conditions in your complete list.
Open the interaction checkerInformation, not medical advice. Do not change prescribed treatment based on this guide.